Drug intelligence / Profile preview

Gengigel Baby

Development stage
Unknown
Lead developer
Ricerfarma
Administration
Topical
01

Overview

Gengigel Baby is a topical oral gel developed by Ricerfarma specifically for pediatric use in infants and children aged 0-6 years. The formulation contains 0.54% hyaluronic acid (sodium hyaluronate) as its active ingredient and is designed as a mucoadhesive gel that forms a protective film over oral tissues. It is indicated for the treatment of gum inflammation and oral mucosal lesions in early childhood, particularly those resulting from teething or oral trauma. The product is free from preservatives, alcohol, colorants, and sugar, using xylitol as a sweetener and featuring a milk and vanilla flavor. It works by providing a physical barrier that hydrates the tissue, reduces pain and swelling, and supports natural mucosal healing. As a biologic formulation based on a naturally occurring component of healthy gingival tissue, it is safe if swallowed and can be used without restriction in infants.

Brand names
Gengigel Baby
Other names
GENGIGEL Baby
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Gengigel Baby.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gengigel Baby.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call